TY - JOUR
T1 - Prediction of medical morbidity and mortality after acute myocardial infarction in patients at increased psychosocial risk in the Enhancing Recovery in Coronary Heart Disease Patients (ENRICHD) study
AU - Jaffe, Allan S.
AU - Krumholz, Harlan M.
AU - Catellier, Diane J.
AU - Freedland, Kenneth E.
AU - Bittner, Vera
AU - Blumenthal, James A.
AU - Calvin, James E.
AU - Norman, James
AU - Sequeira, Rafael
AU - O'Connor, Christopher
AU - Rich, Michael W.
AU - Sheps, David
AU - Wu, Colin
N1 - Funding Information:
This study was supported by contracts NO1-HC-55140, NO1-HC-55141, NO1-HC-55142, NO1-HC-55143, NO1-HC-55144, NO1-HC-55145, NO1-HC-55146, NO1-HC-55147, and NO1-HC-55148. The National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD. Pfizer Inc provided sertraline (Zoloft) for the study.
PY - 2006/7
Y1 - 2006/7
N2 - Background: Patients with myocardial infarction (MI) are at further increased risk for untoward events when patients also exhibit low social support and/or depression. The ENRICHD study was the largest controlled trial in post-MI patients attempting to treat these psychological comorbidities and provides an opportunity to examine the medical and psychological characteristics that may affect risk in this population. Methods: We analyzed the baseline characteristics and their relationship to the primary end point of long-term mortality and recurrent infarction and to the secondary end points of overall mortality and cardiovascular mortality in 2481 post-MI patients. Cox proportional hazards models were used to predict the risk of these outcomes over a mean of 2.5 years of follow-up. Results: Death or nonfatal MI occurred in 24.1%, all-cause mortality in 13.7%, and cardiovascular mortality in 8.4% of the sample (62% of the total). Age, heart failure, pulmonary disease, Killip class, ejection fraction, an elevated creatinine, the use of non-angiotensin-coverting enzyme asodilators, prior MI, diabetes, depression, and bypass surgery after acute MI were all significant multivariable predictors. Conclusions: The medical predictors of adverse events in post-MI patients with low social support and/or depression were similar to those of patients with MI in other clinical trials.
AB - Background: Patients with myocardial infarction (MI) are at further increased risk for untoward events when patients also exhibit low social support and/or depression. The ENRICHD study was the largest controlled trial in post-MI patients attempting to treat these psychological comorbidities and provides an opportunity to examine the medical and psychological characteristics that may affect risk in this population. Methods: We analyzed the baseline characteristics and their relationship to the primary end point of long-term mortality and recurrent infarction and to the secondary end points of overall mortality and cardiovascular mortality in 2481 post-MI patients. Cox proportional hazards models were used to predict the risk of these outcomes over a mean of 2.5 years of follow-up. Results: Death or nonfatal MI occurred in 24.1%, all-cause mortality in 13.7%, and cardiovascular mortality in 8.4% of the sample (62% of the total). Age, heart failure, pulmonary disease, Killip class, ejection fraction, an elevated creatinine, the use of non-angiotensin-coverting enzyme asodilators, prior MI, diabetes, depression, and bypass surgery after acute MI were all significant multivariable predictors. Conclusions: The medical predictors of adverse events in post-MI patients with low social support and/or depression were similar to those of patients with MI in other clinical trials.
UR - http://www.scopus.com/inward/record.url?scp=33745668206&partnerID=8YFLogxK
U2 - 10.1016/j.ahj.2005.10.004
DO - 10.1016/j.ahj.2005.10.004
M3 - Article
C2 - 16824842
AN - SCOPUS:33745668206
SN - 0002-8703
VL - 152
SP - 126
EP - 135
JO - American Heart Journal
JF - American Heart Journal
IS - 1
ER -